ProBiotix Health Plc (AQU:PBX)
8.25
-0.25 (-2.94%)
At close: Jun 5, 2025
ProBiotix Health Company Description
ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.
It offers YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support.
The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022.
ProBiotix Health Plc was founded in 2012 and is based in Wakefield, the United Kingdom.
ProBiotix Health Plc
Country | United Kingdom |
Founded | 2012 |
Industry | Biological Products, Except Diagnostic Substances |
Employees | 7 |
CEO | Steen Andersen |
Contact Details
Address: First Floor Zucchi Suite Wakefield, WF4 1AB United Kingdom | |
Website | probiotixhealth.com |
Stock Details
Ticker Symbol | PBX |
Exchange | Aquis Exchange |
Fiscal Year | January - December |
Reporting Currency | GBP |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Steen Andersen | Chief Executive Officer |